ANTIDIABETIC AND LIPID LOWERING EXTENUATING IMPACT OF GLYCINE MAX LEAVES (SOYABEAN) IN TYPE II DIABETES MELLITUS SUBJECTS

Diabetes mellitus is possibly the world’s largest growing metabolic disease. Currently, a challenge is to identify such healthy foods that remain in the realms of obscurity and to establish them as functional foods to prevent the progression of metabolic complications. Glycine max is indigenous to India and is used extensively in the traditional system of medicine to treat diabetes, reduces coronary heart disease, lowers cholesterol level and other myriad ailments. Therefore, the objective of the study was undertaken to evaluate the effect of Glycine max leaves powder on type II diabetes mellitus subjects. The present study was conducted on type II diabetes mellitus subjects of the middle-income group which were selected from the main campus of Banasthali Vidyapith, Newai Rajasthan and divided into two groups, i.e., experimental (A) and control (B) groups (Age group: 40-60 years). Glycine max 10g leaves powder was incorporated in biscuits and administered to the experimental group daily for 60 days. Biochemical evaluations of blood sample of subjects were done. The present study indicates that Glycine max leaves powder showed a significant effect on blood glucose and lipid parameters. There is a significant decrease in pre and postprandial blood glucose level, glycosylated Hb, total cholesterol, total triglycerides, LDL-C, VLDL-C. There is no significant change in HDL-C may be due to the short period of supplementation. Glycine max purports to alleviate the symptoms of diabetes naturally with no adverse effects on health and low cost or inexpensive than the other hypoglycemic drugs.